---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-012031"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2024-09-17T23:59:59+00:00"
generated_at: "2026-05-31T04:22:11.408437+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Dermata raises $3.5M gross in private placement; expects cash runway into Q2 2025

## Summary
- Gross proceeds $3.5M from 1,912,569 shares/pre-funded warrants + Series A & B warrants at $1.83/unit.
- Net proceeds ~$3.0M after placement agent fees; H.C. Wainwright acted as exclusive agent.
- Series A warrants (5.5 yr term) and Series B warrants (18 mo term) each exercisable at $1.58/share.
- Including prior raises, total $7.8M gross since May 2024; operations funded into Q2 2025.
- Proceeds for general corporate purposes including R&D, clinical trials, and licensing.

## SEC filing metadata
- accession: 0001654954-24-012031
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2024-09-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495424012031/0001654954-24-012031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495424012031/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-012031
- JSON: https://secwatch.observer/filing/0001654954-24-012031.json
- Plain text: https://secwatch.observer/filing/0001654954-24-012031.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.